seeland.ch

2 Einträge von mit inherited mobility

clinicalodyssey.com

Datum der Indexierung 03.05.2024 22:10:02
Subdomain:
extern (outbound) Link/Domain 2 in .clinicalodyssey.com
intern (inbound) Link/Domain .clinicalodyssey.com
Alle Links in alle Links in .clinicalodyssey.com
Kombination Keywords gene lack | retinal your | light particles | clinical reactions | therapy vision | that inherited | cells test | visual viral | patient protein | into this |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Inherited retinal diseases Inherited retinal diseases are a group of genetic conditions that cause degradation of the light-sensitive cells in the retina. Frequently progressive and irreversible, these diseases result in significant vision loss. Degr mobility test. Multi-luminance mobility test In a multi-luminance mobility test, the patient is placed inside a room containing obstacles and arrows on the floor. The patient is asked to navigate different routes and avoid obstacl
Text Inhalt Text aus URL
Log Metriken 12442
URL /lm/em-gene-therapy-leber-congenital-amaurosis-gene-therapy-leber-congenital-amaurosis

www.cslbehring.ch

Datum der Indexierung 04.10.2024 23:30:14
erkannte Namen Ria STAP | Norbert Heimberger | Asia Pacific |
Subdomain:
extern (outbound) Link/Domain 9 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description CSL Behring – a specialist in biotherapeutics for more than 100 years
Kombination Keywords behring more | first your | plasma plant | with award | approved approval | patients bern | treatment switzerland | factor immunglobulin | company rare | market production |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
inherited angioedema in these countries can be helped too. 2008 Professor Heimberger Research Award founded CSL Behring founds a research award in order to honour the achievements of a new generation of specialist in coagulation disorders. The award mobility easier. 2009 Berinert® – the first method of treatment for acute HAE attacks in the U.S. The U.S. Food and Drug Administration (FDA) issued the market license for Berinert® C1 esterase inhibitors, the country’s first and
Text Inhalt Text aus URL
Log Metriken 86083
URL /en-us/our-company/our-story

Menu

  • Home
  • Dokumente
  • Namen
  • Keywords (Text)
  • Links
  • Domain
  • externe links
  • interne links
  • Subdomain
  • Statistik
  • Impressum